Montreal 9 November 2005--A multidisciplinary team consisting of researchers from McGill/MUHC and the CHUM have been awarded a grant of nearly $700,000 by the Canadian Institutes of Health Research (CIHR) to continue their groundbreaking research on pain suffered by some women during sexual intercourse. The new funding will allow the team, consisting of psychologists, gynecologists, physical therapists and statistician/epidemiologists, to root-out the cause of a condition experienced recurrently by at least 15% of Canadian women.

The research team will focus specifically on two main areas of study: dyspareunia (pain during sexual intercourse) and vaginismus (vaginal spasm preventing intercourse). These conditions, which were previously considered sexual dysfunctions, are now increasingly understood as pain disorders as a result of previous research by this team. "Approaching this problem in the context of pain is a more accurate and positive step," says the study's lead researcher Dr. Irv Binik, Director of the Sex and Couple Therapy Service at the MUHC and Professor of Psychology at McGill University. "It opens the door to new therapeutic possibilities including cognitive-behavioral pain management, physical therapy, surgery and alternate pain medication, which will hopefully result in fewer women suffering in silence."

The new CIHR grant will allow the team to initiate research with groups of women that suffer from genital pain associated with menopause--one of the most common forms of dyspareunia. The research concerning vaginismus will focus on the role of fear in sexual intercourse--the major roadblock to therapeutic efforts. "Women suffering from vaginismus seem to avoid and fear vaginal penetration more than women suffering from other genital pain disorders," noted Dr. Binik. "A better understanding of the specific features of both vaginismus and dyspareunia will undoubtedly lead to more appropriate and effective treatments."

Patients
'"/>

Contact: Ian Popple
ian.popple@muhc.mcgill.ca
514-843-1560
McGill University
9-Nov-2005

Page: 1 2
Related medicine news :

1. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators
2. The Burroughs Wellcome Fund awards $8 million to infectious disease investigators
3. Gladstone investigators identify a new protective action for the powerful anti-HIV factor, APOBEC3G
4. Telebriefing: NIH announces program for new scientific investigators
5. BIDMC investigators receive award to study pathways responsible for obesity, type 2 diabetes
6. 1 of 2 pediatric kidney disease research centers in world established
7. Stanford researchers find culprit in aging muscles that heal poorly
8. Researchers suggest TB screening for all international adoptees
9. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
10. Galileo to support global search and rescue
11. Indiana University Imaging Center receives $6M grant for kidney research